The effectiveness of nonsteroidal anti-inflammatory agents in the treatment of pelvic inflammatory disease: a systematic review
review
OA: gold
CC0
⤵ 5 in-corpus citations
Abstract
BACKGROUND: Pelvic inflammatory disease (PID) is the result of infection ascending through the endocervix to the uterus and fallopian tubes. Inflammation driven by infected host cells appears to be central to the development of tissue damage and associated reproductive complications. Nonsteroidal anti-inflammatory agents (NSAIDs) therefore have the potential to reduce the sequelae associated with pelvic infection. METHODS: A search of four electronic reference databases, an internet search for relevant grey literature and a review of the bibliographies of identified publications was used to identify studies evaluating NSAIDs in the management of PID. A predefined search strategy was used to identify studies that included women with PID aged over 16 and diagnosed after 1980. Randomized controlled trials, nonrandomized controlled trials, and cohort studies with comparison group data were included without language restriction. Two reviewers independently assessed the studies against agreed criteria and extracted relevant data using a standardized pro forma. A meta-analysis to calculate the relative risk associated with NSAID use was planned if appropriate. RESULTS: Forty-three studies were identified. After reviewing abstracts or full texts, two randomized controlled trials were found to meet the selection criteria for inclusion. The use of NSAIDs was reported to improve tubal patency, reduce pelvic adhesions and reduce suprapubic pain but the studies were of poor quality with a high risk of bias. Meta-analysis of the data was not performed. CONCLUSIONS: Insufficient data is available to support or refute the efficacy of NSAIDs in the prevention of short or long-term complications of PID.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial via openalex
- Nimesulide in the Treatment of Pelvic Inflammatory Diseases via openalex
- W1866384779 via openalex
- W1983320216 via openalex
- W1987881121 via openalex
- W1990030459 via openalex
- W2023829459 via openalex
- W2027902414 via openalex
- W2043710276 via openalex
- W2077179057 via openalex
- W2083748640 via openalex
- W2085872205 via openalex
- W2087063035 via openalex
- W2102464150 via openalex
- W2137776258 via openalex
- W2170717609 via openalex
- W2318435737 via openalex
- W2397533240 via openalex
- W2400427207 via openalex
- W2410565329 via openalex
- W2418093824 via openalex
- W2470586539 via openalex
- W2472579671 via openalex
- W1554040650 via openalex
- W2573317842 via openalex
- W1598602811 via openalex
Cited by (5)
- ZY5301 Tablet vs Placebo for Treatment of Chronic Pelvic Pain After Pelvic Inflammatory Disease 2024
- Nonsteroidal anti-inflammatory drugs for management of pelvic pain in women 2019
- Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease 2018
- Risk of psychiatric disorders following pelvic inflammatory disease: a nationwide population-based retrospective cohort study 2016
- Effect of Danzhi decoction on expression of angiogenesis factors in patients with sequelae of pelvic inflammatory disease 2014
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK